A study by Dr. Michael Parchman and the American Board of Family Medicine could help doctors have more time for patient care.
Health execs want more actionable data to improve quality and reduce cost. Dr. Eric Larson reflects on a survey GHRI recently led for the IOM.
Link to cumulative use of anticholinergic drugs persists in University of Washington-Group Health study in JAMA Internal Medicine.
U.S. Preventive Services Task Force appoints him vice chair.
Dr. Mike Jackson considers early estimates of the 2014-2015 flu vaccine’s effectiveness, based on data from Group Health and four other sites nationwide.
GHRI invites researchers, collaborators, study participants, and patients to share news and views on Group Health research for leading healthier lives.